These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34373089)

  • 1. Molecular Pathology of Lung Cancer.
    Roy-Chowdhuri S
    Surg Pathol Clin; 2021 Sep; 14(3):369-377. PubMed ID: 34373089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathology of Lung Cancer.
    Roy-Chowdhuri S
    Clin Lab Med; 2024 Jun; 44(2):137-147. PubMed ID: 38821637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
    Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.
    Taniere P; Nicholson AG; Gosney JR; Montero Fernandez MA; Bury D; Moore DA; Verghese E; Soomro I; Joseph L; Bhatt N; Viola P; Bains R; Lanctot AG; Ryan J
    J Clin Pathol; 2024 Jun; 77(7):486-494. PubMed ID: 37258251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma.
    DiBardino DM; Saqi A; Elvin JA; Greenbowe J; Suh JH; Miller VA; Ali SM; Stoopler M; Bulman WA
    Clin Lung Cancer; 2016 Nov; 17(6):517-522.e3. PubMed ID: 27378171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.
    Kerr KM; Bibeau F; Thunnissen E; Botling J; Ryška A; Wolf J; Öhrling K; Burdon P; Malapelle U; Büttner R
    Lung Cancer; 2021 Apr; 154():161-175. PubMed ID: 33690091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive markers in lung cancer: a few hints for the practicing pathologist.
    Barbareschi M; Barberis M; Buttitta F; Doglioni C; Fiorentino M; Fontanini G; Franco R; Marchetti A; Rossi G; Troncone G
    Pathologica; 2018 Mar; 110(1):29-38. PubMed ID: 30259911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.
    Leighl NB; Rekhtman N; Biermann WA; Huang J; Mino-Kenudson M; Ramalingam SS; West H; Whitlock S; Somerfield MR
    J Clin Oncol; 2014 Nov; 32(32):3673-9. PubMed ID: 25311215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates in pathology and molecular diagnostics to inform the evolving landscape of thoracic surgery and oncology.
    Naso J; Lo YC; Sholl LM
    J Surg Oncol; 2023 Feb; 127(2):244-257. PubMed ID: 36630101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review.
    Jain D; Roy-Chowdhuri S
    Arch Pathol Lab Med; 2018 Sep; 142(9):1127-1133. PubMed ID: 29547001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.
    Vigneswaran J; Tan YH; Murgu SD; Won BM; Patton KA; Villaflor VM; Hoffman PC; Hensing T; Hogarth DK; Malik R; MacMahon H; Mueller J; Simon CA; Vigneswaran WT; Wigfield CH; Ferguson MK; Husain AN; Vokes EE; Salgia R
    Oncotarget; 2016 Apr; 7(14):18876-86. PubMed ID: 26934441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of non-small cell lung cancer in the molecular era.
    Brainard J; Farver C
    Mod Pathol; 2019 Jan; 32(Suppl 1):16-26. PubMed ID: 30600321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic testing for lung adenocarcinomas: a practical approach to clinically relevant mutations and translocations.
    Dacic S
    J Clin Pathol; 2013 Oct; 66(10):870-4. PubMed ID: 23801495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges.
    Canberk S; Engels M
    Virchows Arch; 2021 Jan; 478(1):45-57. PubMed ID: 33389149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer biomarkers: present status and future developments.
    Cagle PT; Allen TC; Olsen RJ
    Arch Pathol Lab Med; 2013 Sep; 137(9):1191-8. PubMed ID: 23991729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing.
    Prabhash K; Advani SH; Batra U; Biswas B; Chougule A; Ghosh M; Muddu VK; Sahoo TP; Vaid AK
    Adv Ther; 2019 Apr; 36(4):766-785. PubMed ID: 30864106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molecular Pathology of Lung Cancer.
    Sholl LM
    Surg Pathol Clin; 2016 Sep; 9(3):353-78. PubMed ID: 27523966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive targetable genotypes of younger patients with lung adenocarcinoma: a cBioPortal for cancer genomics data base analysis.
    Hou H; Zhang C; Qi X; Zhou L; Liu D; Lv H; Li T; Sun D; Zhang X
    Cancer Biol Ther; 2020; 21(1):26-33. PubMed ID: 31594446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology of non-small cell lung cancer: a practical guide.
    Aisner DL; Marshall CB
    Am J Clin Pathol; 2012 Sep; 138(3):332-46. PubMed ID: 22912349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates in Lung Cancer Cytopathology.
    VanderLaan PA
    Surg Pathol Clin; 2018 Sep; 11(3):515-522. PubMed ID: 30190138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.